Duration of seropositivity following yellow fever vaccination in U.S. military service members. Issue 52 (14th December 2020)

• Record Type: Journal Article
• Authors: Lindsey, Nicole P.; Perry, Lori; Fischer, Marc; Woolpert, Tabitha; Biggerstaff, Brad J.; Brice, Gary; Fitzpatrick, Kelly; Kosoy, Olga I.; Laven, Janeen J.; Myers, Christopher A.; Hollis, Ewell M; Staples, J. Erin
• Is Part Of: Vaccine. Volume 38:Issue 52(2020)
• Page Start: 8286
• Page End: 8291
• Publication Date: 2020-12-14
• Subjects: Yellow fever -- Vaccine -- Seropositivity -- Military; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2020.11.022
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Background: The United States military regularly deploys thousands of service members throughout areas of South America and Africa that are endemic for yellow fever (YF) virus. To determine if booster doses might be needed for service members who are repetitively or continually deployed to YF endemic areas, we evaluated seropositivity among US military personnel receiving a single dose of YF vaccine based on time post-vaccination. Methods: Serum antibodies were measured using a plaque reduction neutralization test with 50% cutoff in 682 military personnel at 5–39 years post-vaccination. We determined noninferiority of immune response by comparing the proportion seropositive among those vaccinated 10–14 years previously with those vaccinated 5–9 years previously. Noninferiority was supported if the lower-bound of the 2-tailed 95% CI for p 10-14years – p 5-9years was ≥−0.10. Additionally, the geometric mean antibody titer (GMT) at various timepoints following vaccination were compared to the GMT at 5–9 years. Results: The proportion of military service members with detectable neutralizing antibodies 10–14 years after a single dose of YF vaccine (95.8%, 95% CI 91.2–98.1%) was non-inferior to the proportion 5–9 years after vaccination (97.8%, 95% CI 93.7–99.3%). Additionally, GMT among vaccine recipients at 10–14 years post vaccination (99, 95% CI 82–121) was non-inferior to GMT in YF vaccine recipients at 5–9 years post vaccination (115, 95% CI 96–139). The proportion of vaccinees with neutralizing antibodies remained high, and non-inferior, among those vaccinated 15–19 years prior (98.5%, 95%CI 95.5–99.7%). Although the proportion seropositive decreased among vaccinees ≥ 20 years post vaccination, >90% remained seropositive. Conclusions: Neutralizing antibodies were present in > 95% of vaccine recipients for at least 19 years after vaccination, suggesting that booster doses every 10 years are not essential for most U.S. military personnel.